Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Daysaver AG

History from 21 Aug 2020

UID
CHE-422.871.198
Legal form
AG
Canton
ZH
Founded
21 Aug 2020
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 117k
29k59k88k117k23 May 2022 · CHF 100k28 Dec 2022 · CHF 106k17 Jan 2025 · CHF 110k5 Sep 2025 · CHF 117k2022202320242025
  • shares

Record

  1. Company formed

    Founded 21 Aug 2020

    SHAB HR01-1004964678 ↗
  2. Converted to an AG

    GmbH → AG

    SHAB HR02-1005479437 ↗
  3. Capital set in the conversion to an AG

    Not assessed

    Paid by converting claims

    Nominal capital
    25’000 → 100’000
    Shares
    — → 1’000’000
    New shares, % of post-step shares
    — (conversion to an AG)

    Umwandlung: Die Gesellschaft mit beschränkter Haftung hat das Stammkapital auf CHF 100'000.00 erhöht und wird gemäss Umwandlungsplan vom 16.05.2022 und Bilanz per 31.12.2021 mit Aktiven von CHF 113'456.20 und Passiven (Fremdkapital) von CHF 13'456.14 in eine Aktiengesellschaft umgewandelt. Rechtsform neu: Aktiengesellschaft. Aktienkapital neu: CHF 100'000.00 [bisher: CHF 25'000.00]. Liberierung Aktienkapital neu: CHF 100'000.00. Aktien neu: 1'000'000 Namenaktien zu CHF 0.10. Bei der Kapitalerhöhung vom 16.05.2022 wird frei verwendbares Eigenkapital in der Höhe von CHF 53'021.80 umgewandelt.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005479437 ↗
  4. Name changed

    B-Men GmbH → Daysaver AG

    SHAB HR02-1005479437 ↗
  5. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    100’000 → 105’555.70
    Shares
    1’000’000 → 1’055’557
    New shares, % of post-step shares
    5.3% (55’557 new)

    Aktienkapital neu: CHF 105'555.70 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 105'555.70 [bisher: CHF 100'000.00]. Aktien neu: 1'055'557 Namenaktien zu CHF 0.10 [bisher: 1'000'000 Namenaktien zu CHF 0.10].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005639703 ↗
  6. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    105’555.70 → 109’513.50
    Shares
    1’055’557 → 1’095’135
    New shares, % of post-step shares
    3.6% (39’578 new)

    Aktienkapital neu: CHF 109'513.50 [bisher: CHF 105'555.70]. Liberierung Aktienkapital neu: CHF 109'513.50 [bisher: CHF 105'555.70]. Aktien neu: 1'095'135 Namenaktien zu CHF 0.10 [bisher: 1'055'557 Namenaktien zu CHF 0.10].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006230713 ↗
  7. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    109’513.50 → 117’109.50
    Shares
    1’095’135 → 1’171’095
    New shares, % of post-step shares
    6.5% (75’960 new)

    Aktienkapital neu: CHF 117'109.50 [bisher: CHF 109'513.50]. Liberierung Aktienkapital neu: CHF 117'109.50 [bisher: CHF 109'513.50]. Aktien neu: 1'171'095 Namenaktien zu CHF 0.10 [bisher: 1'095'135 Namenaktien zu CHF 0.10].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.60 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006425634 ↗

Published by 7 Sep 2025

Latest available record · 8 Oct 2026